A reduction in tumor volume by ~ 6 mL and 38 mL was associated with an increased probability of 12-month and 24-month OS, respectively (not statistically significant but approaching significance).
← all excerpts
EORTC/ESTRO defined induced oligopersistence of liver metastases from colorectal cancer - outcomes and toxicity profile of computer tomography guided high-dose-rate brachytherapy.
2
—
—
The sentences
Factors affecting PFS included: the size of the largest metastasis after brachytherapy; TBS difference (borderline significance); mean size of a single metastatic lesion; type of RECIST response; percentage of ORR; and the volume of metastases after brachytherapy.